Segal Lloyd Mitchell
SEC insider (Form 3/4/5 filer). CIK 0001477123. Director at Aktis Oncology, Inc. (AKTS) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 12, 2026. Located in BOSTON, MA.
Companies Segal Lloyd Mitchell has filed insider reports for
- Aktis Oncology, Inc. (AKTS): Director
- Repare Therapeutics Inc. (RPTX): Director, Officer, PRESIDENT AND CEO
Segal Lloyd Mitchell
CIK: 0001477123
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
